Alpha 2.0
Login Register
» Articles » PMID: 14645634

Therapeutic Options for Laryngeal Cancer

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2003 Dec 4
PMID 14645634
Citations 6
Authors
Everett E Vokes
Kerstin M Stenson
Affiliations
Soon will be listed here.
Citing Articles

Prognostic factors of patients with initially diagnosed T1a glottic cancer: Novel nomograms and a propensity-score matched cohort analysis.

Luo M, Huang G, Liu H Medicine (Baltimore). 2020; 99(45):e23004.

PMID: 33157944 PMC: 7647548. DOI: 10.1097/MD.0000000000023004.

Clinical significance of ADAM10 expression in laryngeal carcinoma.

You B, Gu M, Cao X, Li X, Shi S, Shan Y Oncol Lett. 2017; 13(3):1353-1359.

PMID: 28454261 PMC: 5403229. DOI: 10.3892/ol.2016.5546.

DIRC3 and near NABP1 genetic polymorphisms are associated laryngeal squamous cell carcinoma patient survival.

Shen Z, Ren W, Bai Y, Chen Z, Li J, Li B Oncotarget. 2016; 7(48):79596-79604.

PMID: 27793000 PMC: 5346738. DOI: 10.18632/oncotarget.12865.

Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.

Wang R, Guo Y, Ma H, Feng L, Wang Q, Chen X Tumour Biol. 2015; 37(2):2635-45.

PMID: 26395262 DOI: 10.1007/s13277-015-4016-8.

CXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cells.

Niu J, Huang Y, Zhang L Int J Clin Exp Pathol. 2015; 8(6):6255-61.

PMID: 26261502 PMC: 4525836.